FDA Inspection
Eosera, Inc.Eosera, Inc. – FDA Inspection, Apr 28, 2025
Record Details
This FDA Inspection record concerns Eosera, Inc., with an inspection on April 28, 2025, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · d587b33b-e13d-4322-8bcc-32a754573761
Inspection Facts
- Inspection number
- 1269635
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eosera, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| March 1, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 17, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eosera, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.